Hillsdale Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-243,500	Closed	-$4.8M	–	671
2025 Q3	$4.8M	Sell	243,500 -21,300	-8%	-$438K	0.14%	203
2025 Q2	$5.75M	Buy	264,800 +67,700	+34%	+$1.6M	0.21%	118
2025 Q1	$4.78M	Buy	197,100 +7,100	+4%	+$160K	0.24%	73
2024 Q4	$3.97M	Buy	190,000 +100	+0.1%	+$2.15K	0.2%	133
2024 Q3	$3.78M	Buy	+189,900	New	+$3.52M	0.29%	137
2024 Q1	–	Sell	-280	Closed	-$4.71K	–	606
2023 Q4	$4.71K	Sell	280 -80	-22%	-$1.09K	﹤0.01%	541
2023 Q3	$4.21K	Sell	360 -254,960	-100%	-$3.41M	﹤0.01%	544
2023 Q2	$3.43M	Sell	255,320 -80,580	-24%	-$1.16M	0.32%	135
2023 Q1	$5.57M	Sell	335,900 -23,900	-7%	-$394K	0.48%	64
2022 Q4	$6.69M	Sell	359,800 -121,900	-25%	-$1.88M	0.57%	32
2022 Q3	$6.18M	Sell	481,700 -173,900	-27%	-$2.06M	0.56%	39
2022 Q2	$4.59M	Buy	655,600 +5,700	+0.9%	+$41.8K	0.37%	95
2022 Q1	$5.39M	Buy	+649,900	New	+$4.59M	0.35%	93
2018 Q1	–	Sell	-17,000	Closed	-$66K	–	482
2017 Q4	$66K	Buy	+17,000	New	+$56.2K	0.01%	307